Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Risk of Caries and Enamel Abnormalities in Patients With Cleft Palate

The goal of this interventional (non-drug, non-device) clinical study is to learn whether children and adolescents born with a cleft lip and/or palate have more tooth decay (dental caries) and more defects of the tooth enamel than children without a cleft, and whether these problems are linked to the type of cleft and to the surgeries these patients have received. In other words, the study aims to find out whether children whose cleft involves the lip and/or the alveolus (the tooth-bearing part of the upper jaw) have a higher risk of caries in the front teeth of the upper jaw.

The main questions it aims to answer are:

Do children with a cleft have a higher caries experience and a higher caries risk than children of the same age without a cleft? In other words, do children with a cleft involving the lip and/or the alveolus have a higher caries risk in the upper front (maxillary anterior) teeth? Are enamel defects (such as hypomineralisation or hypoplasia) more frequent in children with a cleft, where in the mouth are they mainly located, and are they associated with the cleft type or with specific surgical procedures? Do factors such as parental education level, eating habits, oral hygiene habits and the mobility of the scarred upper lip influence the number and the location of caries lesions? Researchers will compare about 200 patients aged 2 to 18 years with any type of cleft (isolated cleft lip, isolated cleft palate, or cleft lip and alveolus with or without cleft palate; with or without an associated syndrome), followed at the Cleft Lip and Palate Centre of the Cliniques universitaires Saint-Luc (Brussels, Belgium), with about 200 children and adolescents of the same age (plus or minus 1 year) without a cleft or syndrome, seen for a routine visit in the paediatric dentistry department of the same hospital.

No drug, device or treatment is tested, and participants' usual care will not be changed. The study adds standardised questionnaires and study-specific clinical assessments to a dental visit that is already planned as part of their regular follow-up. During this visit, participants will:

Have a standard oral examination to record decayed D, missing M and filled F teeth T (DMFT index) in primary and permanent teeth; Have their teeth screened for enamel defects using a standardised European method ( Developmental Defects of Enamel Index ); Have the mobility of their upper lip assessed with a clinical scale (cleft group only), because surgical scars can make brushing of the front teeth more difficult; Possibly have intra-oral photographs taken to document the findings (dental X-rays are only taken if clinically needed for their usual care, never for the study alone).

Parents or legal guardians will fill in short questionnaires about the child's medical and dental history, oral hygiene and eating habits, exposure to protective and risk factors for caries (CAMBRA Caries Management by Risk Assessment), and early-life factors that may be associated with enamel defects.

Participation takes place in a single visit and does not require any additional appointment. There is no direct individual benefit for participants, and the risks are minimal because only routine examinations and questionnaires are used. The results are expected to help identify children with a cleft who are at high risk of caries early on, to show which teeth are most vulnerable, and to design prevention strategies better adapted to these patients (for example, oral hygiene advice and tools adapted to the scarred upper lip).

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Tipo di studio

Interventistico

Iscrizione (Stimato)

400

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Brabant Flamand
      • Brussels, Brabant Flamand, Belgio, 1200
        • Cliniques universitaires Saint-Luc
        • Contatto:
        • Contatto:
          • Pierre Mahy, MD, DDS, PhD
        • Sub-investigatore:
          • Fanny Deghorain, DDS, MSc (Paediatric Dentistry
        • Investigatore principale:
          • Pierre Mahy, MD, DDS, PhD

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 2 anni a 18 anni (Bambino, Adulto)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

Cleft group:

  • Children and adolescents aged 2 to 18 years
  • Any cleft phenotype (isolated cleft lip, isolated cleft palate, cleft lip and alveolus, cleft lip and palate), unilateral (left or right) or bilateral
  • With or without an associated syndrome
  • Primary and/or permanent teeth present
  • Followed at the Cleft Lip and Palate Centre of the Cliniques universitaires Saint-Luc

Control group:

  • Healthy children and adolescents aged 2 to 18 years
  • No cleft lip and/or palate
  • Followed at the Cliniques universitaires Saint-Luc (paediatric dentistry, routine annual check-up or consultation within the Institute of Dental Medicine and Stomatology - IMDS)
  • Primary and/or permanent teeth present

Exclusion Criteria:

Cleft group:

  • Edentulous patients (no teeth)

Control group:

  • Edentulous patients (no teeth)

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Non randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Cleft group

Children and adolescents aged 2 to 18 years with any type of cleft lip and/or palate (with or without an associated syndrome), followed at the Cleft Lip and Palate Centre of the Cliniques universitaires Saint-Luc.

Single study visit during a routine dental consultation (standard of care), with study-specific standardised assessments: caries experience (dmft/DMFT, recorded tooth by tooth Decayed, Missing, Filled Teeth), enamel defect screening (Ghanim et al. 2015, modified DDE Developmental Defects of Enamel index), and CAMBRA (Caries Management by Risk Assessment). Parents complete standardised questionnaires on the child's medical and dental history, oral hygiene and dietary habits, and early-life factors associated with enamel defects. In the cleft group only, upper lip mobility is assessed with a clinical scale. Intra-oral photographs may be taken. No drug, device or treatment is tested, and no radiographs are taken for study purposes only.

Altro: Control group

Children and adolescents aged 2 to 18 years without a cleft or syndrome, age-matched (± 1 year) to the cleft group, seen for a routine visit in paediatric dentistry at the Cliniques universitaires Saint-Luc.

Single study visit during a routine dental consultation (standard of care), with study-specific standardised assessments: caries experience (dmft/DMFT, recorded tooth by tooth Decayed, Missing, Filled Teeth), enamel defect screening (Ghanim et al. 2015, modified DDE Developmental Defects of Enamel index), and CAMBRA (Caries Management by Risk Assessment). Parents complete standardised questionnaires on the child's medical and dental history, oral hygiene and dietary habits, and early-life factors associated with enamel defects. In the cleft group only, upper lip mobility is assessed with a clinical scale. Intra-oral photographs may be taken. No drug, device or treatment is tested, and no radiographs are taken for study purposes only.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Caries experience assessed by the dmft/DMFT index in patients with cleft lip and/or palate compared with age-matched controls
Lasso di tempo: Throughout the entire study, approximately during 20 months

Caries experience will be assessed by clinical oral examination by a calibrated examiner using the dmft index (decayed, missing and filled primary teeth) and/or the DMFT index (Decayed, Missing and Filled permanent Teeth), according to WHO diagnostic criteria. Scores range from 0 to 20 for dmft and from 0 to 28/32 for DMFT. Higher scores indicate greater caries experience. Mean scores will be compared between children with cleft lip and/or palate and age-matched controls.

Throughout the entire study, approximately during 20 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Prevalence of developmental defects of enamel in patients with cleft compared with controls
Lasso di tempo: Throughout the entire study, approximately during 20 months
Throughout the entire study, approximately during 20 months
Localisation of developmental defects of enamel assessed by the modified DDE index in patients with cleft compared with controls
Lasso di tempo: Throughout the entire study, approximately during 20 months

Developmental defects of enamel will be recorded by clinical oral examination by a calibrated examiner using the MIH/HSPM long recording sheet (Ghanim et al., 2015), which includes MIH/HSPM and modified DDE characteristics on all erupted teeth. For each tooth and surface (buccal, occlusal/incisal, palatal/lingual), the defect type will be scored from 0 to 7 (0 = no defect; 1 = non-MIH/HSPM defect: diffuse opacity, hypoplasia, amelogenesis imperfecta, hypomineralisation; 2 = demarcated opacity; 3 = post-eruptive enamel breakdown; 4 = atypical restoration; 5 = atypical caries; 6 = missing due to MIH/HSPM; 7 = cannot be scored). Lesion extent will be graded I to III (<1/3, 1/3-2/3, ≥2/3 of the surface). Severity will be classified as mild or severe according to EAPD criteria. The distribution of defects by tooth, surface and cleft side will be compared between groups.

Throughout the entire study, approximately during 20 months
Correlation between dietary, oral hygiene and socio-economic factors assessed by the CAMBRA form (Caries Management by Risk Assessment) and caries experience (dmft/DMFT index)
Lasso di tempo: Throughout the entire study, approximately during 20 months

Risk factors will be recorded using the French version of the CAMBRA caries risk assessment form (Doméjean et al., 2025), age-specific version (0-6 years or >6 years). Each item is scored as present/absent (yes/no): dietary factors (frequent snacking >3 times/day; bottle or cup with liquids other than water, 0-6 y), oral hygiene factors (fluoride toothpaste at least twice daily; visible dental plaque) and socio-economic factor (low family socio-economic status and/or low health literacy, 0-6 y). Caries experience will be measured as dmft/DMFT score.

Throughout the entire study, approximately during 20 months
Correlation between upper lip mobility (clinical eversion score 0-3 and photographic lip mobility in mm) and anterior caries experience (dmft/DMFT index) in patients with cleft
Lasso di tempo: Throughout the entire study, approximately during 20 months

Upper lip mobility will be assessed in the cleft group by two methods: (1) a clinical eversion score from 0 to 3 (0 = normal mobility, full access to labial surfaces of maxillary anterior teeth; 1 = slightly reduced; 2 = moderately reduced, cervical third of incisors hardly accessible; 3 = severely reduced, tense lip, labial surfaces hardly accessible to brushing) (2) standardised peri-oral photographs at rest and at maximal smile, with lip mobility calculated as the difference in incisal exposure (smile minus rest, in mm). Anterior caries experience will be measured as the dmft/DMFT score of maxillary anterior teeth.

Throughout the entire study, approximately during 20 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

14 dicembre 2026

Completamento primario (Stimato)

31 dicembre 2027

Completamento dello studio (Stimato)

30 giugno 2028

Date di iscrizione allo studio

Primo inviato

29 settembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

3 novembre 2026

Primo Inserito (Effettivo)

9 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

9 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

3 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi